Cethrin in Acute Cervical Spinal Cord Injury

Summary

This is a multicenter, randomized, double-blind, placebo-controlled Phase IIb/III study designed to evaluate the efficacy and safety of Cethrin as a treatment for acute cervical spinal cord injury. During the trial, high and low doses of Cethrin will be compared with placebo.

Timeline

Start

2015-07

Primary completion

2016-05

Completion

—

Outcome

Outcome not reported

Stopped: “Compound recently partnered with another company for continued development.”

Drugs

Indications